June 1, 2015

ICYMI: Better Medicare Alliance Urges Congress to Protect Seniors’ Medicare Drug Benefits

In a recent letter to House leadership, the Better Medicare Alliance urges Congress to reconsider shifting funds from Part D drug benefits to the 21st Century Cures Act, which neither reduces the cost of pharmaceuticals nor enhances seniors’ access to life-saving medications. The letter was signed by Dr. Elena Rios, President of the National Hispanic Medical Association, a BMA ally, and addressed to Speaker of the House John Boehner and Democratic Leader Nancy Pelosi.

Below are highlights from the letter:

  • “While we support the Act’s intention to increase investments in medical research and development of new drugs, devices and treatments, we oppose the method used to finance these new investments.”
  • “This action could make it more expensive for seniors to access the very cures that may result from these investments in research and development of new drugs. This is a harmful and unnecessary tradeoff between two important programs dedicated to improving health outcomes for seniors and those with disabilities who rely on Part D drug benefits.”
  • “We ask you to reconsider the use of delayed reinsurance payments to Medicare Part D drug plans as the proposed budget offset and replace it with other budget offsets that do not bring potential harm to the Medicare Part D drug benefits that are so critical to seniors and those with disabilities.”


For the full letter, see here.

Sign Up for Policy Alerts

Sign up to receive exclusive updates on Medicare Advantage policy.